- IBDEI1XF ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,30774,0)
- ;;=R33.9^^123^1585^24
- ;;^UTILITY(U,$J,358.3,30774,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30774,1,3,0)
- ;;=3^Urinary Retention,Unspec
- ;;^UTILITY(U,$J,358.3,30774,1,4,0)
- ;;=4^R33.9
- ;;^UTILITY(U,$J,358.3,30774,2)
- ;;=^5019332
- ;;^UTILITY(U,$J,358.3,30775,0)
- ;;=D51.8^^123^1586^2
- ;;^UTILITY(U,$J,358.3,30775,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30775,1,3,0)
- ;;=3^Anemia,Vitamin B12 Deficiency
- ;;^UTILITY(U,$J,358.3,30775,1,4,0)
- ;;=4^D51.8
- ;;^UTILITY(U,$J,358.3,30775,2)
- ;;=^5002288
- ;;^UTILITY(U,$J,358.3,30776,0)
- ;;=D52.9^^123^1586^1
- ;;^UTILITY(U,$J,358.3,30776,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30776,1,3,0)
- ;;=3^Anemia,Folate Deficiency
- ;;^UTILITY(U,$J,358.3,30776,1,4,0)
- ;;=4^D52.9
- ;;^UTILITY(U,$J,358.3,30776,2)
- ;;=^5002293
- ;;^UTILITY(U,$J,358.3,30777,0)
- ;;=I10.^^123^1587^12
- ;;^UTILITY(U,$J,358.3,30777,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30777,1,3,0)
- ;;=3^Hypertension,Essential
- ;;^UTILITY(U,$J,358.3,30777,1,4,0)
- ;;=4^I10.
- ;;^UTILITY(U,$J,358.3,30777,2)
- ;;=^5007062
- ;;^UTILITY(U,$J,358.3,30778,0)
- ;;=I15.0^^123^1587^13
- ;;^UTILITY(U,$J,358.3,30778,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30778,1,3,0)
- ;;=3^Hypertension,Renovascular
- ;;^UTILITY(U,$J,358.3,30778,1,4,0)
- ;;=4^I15.0
- ;;^UTILITY(U,$J,358.3,30778,2)
- ;;=^5007071
- ;;^UTILITY(U,$J,358.3,30779,0)
- ;;=I13.11^^123^1587^8
- ;;^UTILITY(U,$J,358.3,30779,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30779,1,3,0)
- ;;=3^HTN Hrt & CKD w/o Hrt Failure w/ Stage 5 Chr Kidney/ESRD
- ;;^UTILITY(U,$J,358.3,30779,1,4,0)
- ;;=4^I13.11
- ;;^UTILITY(U,$J,358.3,30779,2)
- ;;=^5007069
- ;;^UTILITY(U,$J,358.3,30780,0)
- ;;=I13.2^^123^1587^7
- ;;^UTILITY(U,$J,358.3,30780,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30780,1,3,0)
- ;;=3^HTN Hrt & CKD w/ Hrt Failure w/ Stage 5 Chr Kidney/ESRD
- ;;^UTILITY(U,$J,358.3,30780,1,4,0)
- ;;=4^I13.2
- ;;^UTILITY(U,$J,358.3,30780,2)
- ;;=^5007070
- ;;^UTILITY(U,$J,358.3,30781,0)
- ;;=I70.1^^123^1587^3
- ;;^UTILITY(U,$J,358.3,30781,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30781,1,3,0)
- ;;=3^Atherosclerosis of Renal Artery
- ;;^UTILITY(U,$J,358.3,30781,1,4,0)
- ;;=4^I70.1
- ;;^UTILITY(U,$J,358.3,30781,2)
- ;;=^269760
- ;;^UTILITY(U,$J,358.3,30782,0)
- ;;=I77.3^^123^1587^2
- ;;^UTILITY(U,$J,358.3,30782,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30782,1,3,0)
- ;;=3^Arterial Fibromuscular Dysplasia
- ;;^UTILITY(U,$J,358.3,30782,1,4,0)
- ;;=4^I77.3
- ;;^UTILITY(U,$J,358.3,30782,2)
- ;;=^5007812
- ;;^UTILITY(U,$J,358.3,30783,0)
- ;;=E26.02^^123^1587^5
- ;;^UTILITY(U,$J,358.3,30783,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30783,1,3,0)
- ;;=3^Glucocorticoid-Remediable Aldosteronism
- ;;^UTILITY(U,$J,358.3,30783,1,4,0)
- ;;=4^E26.02
- ;;^UTILITY(U,$J,358.3,30783,2)
- ;;=^329904
- ;;^UTILITY(U,$J,358.3,30784,0)
- ;;=I12.9^^123^1587^14
- ;;^UTILITY(U,$J,358.3,30784,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30784,1,3,0)
- ;;=3^Hypertensive CKD Stage 1-4
- ;;^UTILITY(U,$J,358.3,30784,1,4,0)
- ;;=4^I12.9
- ;;^UTILITY(U,$J,358.3,30784,2)
- ;;=^5007066
- ;;^UTILITY(U,$J,358.3,30785,0)
- ;;=I12.0^^123^1587^15
- ;;^UTILITY(U,$J,358.3,30785,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,30785,1,3,0)
- ;;=3^Hypertensive CKD Stage 5 or ESRD
- ;;^UTILITY(U,$J,358.3,30785,1,4,0)
- ;;=4^I12.0
- ;;^UTILITY(U,$J,358.3,30785,2)
- ;;=^5007065
- ;;^UTILITY(U,$J,358.3,30786,0)
- ;;=I13.0^^123^1587^6
- ;;^UTILITY(U,$J,358.3,30786,1,0)
- ;;=^358.31IA^4^2
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1XF 3790 printed Dec 13, 2024@02:17:40 Page 2
- IBDEI1XF ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,30774,0)
- +2 ;;=R33.9^^123^1585^24
- +3 ;;^UTILITY(U,$J,358.3,30774,1,0)
- +4 ;;=^358.31IA^4^2
- +5 ;;^UTILITY(U,$J,358.3,30774,1,3,0)
- +6 ;;=3^Urinary Retention,Unspec
- +7 ;;^UTILITY(U,$J,358.3,30774,1,4,0)
- +8 ;;=4^R33.9
- +9 ;;^UTILITY(U,$J,358.3,30774,2)
- +10 ;;=^5019332
- +11 ;;^UTILITY(U,$J,358.3,30775,0)
- +12 ;;=D51.8^^123^1586^2
- +13 ;;^UTILITY(U,$J,358.3,30775,1,0)
- +14 ;;=^358.31IA^4^2
- +15 ;;^UTILITY(U,$J,358.3,30775,1,3,0)
- +16 ;;=3^Anemia,Vitamin B12 Deficiency
- +17 ;;^UTILITY(U,$J,358.3,30775,1,4,0)
- +18 ;;=4^D51.8
- +19 ;;^UTILITY(U,$J,358.3,30775,2)
- +20 ;;=^5002288
- +21 ;;^UTILITY(U,$J,358.3,30776,0)
- +22 ;;=D52.9^^123^1586^1
- +23 ;;^UTILITY(U,$J,358.3,30776,1,0)
- +24 ;;=^358.31IA^4^2
- +25 ;;^UTILITY(U,$J,358.3,30776,1,3,0)
- +26 ;;=3^Anemia,Folate Deficiency
- +27 ;;^UTILITY(U,$J,358.3,30776,1,4,0)
- +28 ;;=4^D52.9
- +29 ;;^UTILITY(U,$J,358.3,30776,2)
- +30 ;;=^5002293
- +31 ;;^UTILITY(U,$J,358.3,30777,0)
- +32 ;;=I10.^^123^1587^12
- +33 ;;^UTILITY(U,$J,358.3,30777,1,0)
- +34 ;;=^358.31IA^4^2
- +35 ;;^UTILITY(U,$J,358.3,30777,1,3,0)
- +36 ;;=3^Hypertension,Essential
- +37 ;;^UTILITY(U,$J,358.3,30777,1,4,0)
- +38 ;;=4^I10.
- +39 ;;^UTILITY(U,$J,358.3,30777,2)
- +40 ;;=^5007062
- +41 ;;^UTILITY(U,$J,358.3,30778,0)
- +42 ;;=I15.0^^123^1587^13
- +43 ;;^UTILITY(U,$J,358.3,30778,1,0)
- +44 ;;=^358.31IA^4^2
- +45 ;;^UTILITY(U,$J,358.3,30778,1,3,0)
- +46 ;;=3^Hypertension,Renovascular
- +47 ;;^UTILITY(U,$J,358.3,30778,1,4,0)
- +48 ;;=4^I15.0
- +49 ;;^UTILITY(U,$J,358.3,30778,2)
- +50 ;;=^5007071
- +51 ;;^UTILITY(U,$J,358.3,30779,0)
- +52 ;;=I13.11^^123^1587^8
- +53 ;;^UTILITY(U,$J,358.3,30779,1,0)
- +54 ;;=^358.31IA^4^2
- +55 ;;^UTILITY(U,$J,358.3,30779,1,3,0)
- +56 ;;=3^HTN Hrt & CKD w/o Hrt Failure w/ Stage 5 Chr Kidney/ESRD
- +57 ;;^UTILITY(U,$J,358.3,30779,1,4,0)
- +58 ;;=4^I13.11
- +59 ;;^UTILITY(U,$J,358.3,30779,2)
- +60 ;;=^5007069
- +61 ;;^UTILITY(U,$J,358.3,30780,0)
- +62 ;;=I13.2^^123^1587^7
- +63 ;;^UTILITY(U,$J,358.3,30780,1,0)
- +64 ;;=^358.31IA^4^2
- +65 ;;^UTILITY(U,$J,358.3,30780,1,3,0)
- +66 ;;=3^HTN Hrt & CKD w/ Hrt Failure w/ Stage 5 Chr Kidney/ESRD
- +67 ;;^UTILITY(U,$J,358.3,30780,1,4,0)
- +68 ;;=4^I13.2
- +69 ;;^UTILITY(U,$J,358.3,30780,2)
- +70 ;;=^5007070
- +71 ;;^UTILITY(U,$J,358.3,30781,0)
- +72 ;;=I70.1^^123^1587^3
- +73 ;;^UTILITY(U,$J,358.3,30781,1,0)
- +74 ;;=^358.31IA^4^2
- +75 ;;^UTILITY(U,$J,358.3,30781,1,3,0)
- +76 ;;=3^Atherosclerosis of Renal Artery
- +77 ;;^UTILITY(U,$J,358.3,30781,1,4,0)
- +78 ;;=4^I70.1
- +79 ;;^UTILITY(U,$J,358.3,30781,2)
- +80 ;;=^269760
- +81 ;;^UTILITY(U,$J,358.3,30782,0)
- +82 ;;=I77.3^^123^1587^2
- +83 ;;^UTILITY(U,$J,358.3,30782,1,0)
- +84 ;;=^358.31IA^4^2
- +85 ;;^UTILITY(U,$J,358.3,30782,1,3,0)
- +86 ;;=3^Arterial Fibromuscular Dysplasia
- +87 ;;^UTILITY(U,$J,358.3,30782,1,4,0)
- +88 ;;=4^I77.3
- +89 ;;^UTILITY(U,$J,358.3,30782,2)
- +90 ;;=^5007812
- +91 ;;^UTILITY(U,$J,358.3,30783,0)
- +92 ;;=E26.02^^123^1587^5
- +93 ;;^UTILITY(U,$J,358.3,30783,1,0)
- +94 ;;=^358.31IA^4^2
- +95 ;;^UTILITY(U,$J,358.3,30783,1,3,0)
- +96 ;;=3^Glucocorticoid-Remediable Aldosteronism
- +97 ;;^UTILITY(U,$J,358.3,30783,1,4,0)
- +98 ;;=4^E26.02
- +99 ;;^UTILITY(U,$J,358.3,30783,2)
- +100 ;;=^329904
- +101 ;;^UTILITY(U,$J,358.3,30784,0)
- +102 ;;=I12.9^^123^1587^14
- +103 ;;^UTILITY(U,$J,358.3,30784,1,0)
- +104 ;;=^358.31IA^4^2
- +105 ;;^UTILITY(U,$J,358.3,30784,1,3,0)
- +106 ;;=3^Hypertensive CKD Stage 1-4
- +107 ;;^UTILITY(U,$J,358.3,30784,1,4,0)
- +108 ;;=4^I12.9
- +109 ;;^UTILITY(U,$J,358.3,30784,2)
- +110 ;;=^5007066
- +111 ;;^UTILITY(U,$J,358.3,30785,0)
- +112 ;;=I12.0^^123^1587^15
- +113 ;;^UTILITY(U,$J,358.3,30785,1,0)
- +114 ;;=^358.31IA^4^2
- +115 ;;^UTILITY(U,$J,358.3,30785,1,3,0)
- +116 ;;=3^Hypertensive CKD Stage 5 or ESRD
- +117 ;;^UTILITY(U,$J,358.3,30785,1,4,0)
- +118 ;;=4^I12.0
- +119 ;;^UTILITY(U,$J,358.3,30785,2)
- +120 ;;=^5007065
- +121 ;;^UTILITY(U,$J,358.3,30786,0)
- +122 ;;=I13.0^^123^1587^6
- +123 ;;^UTILITY(U,$J,358.3,30786,1,0)
- +124 ;;=^358.31IA^4^2